Abstract
A mouse monoclonal antibody, HAV 4-1, obtained after immunization of a BALB/c mouse with purified C3F, detected a novel genetic polymorphism of human complement component C3 in a simple immunoblotting system. The frequency of HAV 4-1-positive genes was 20.1%. Reactivity of HAV 4-1 was closely related to C3F, but certain individuals with the C3F allele did not react with HAV 4-1. Conversely, certain C3S homozygous individuals did react with HAV 4-1. The polymorphism detected by this monoclonal antibody is therefore different from the previously described polymorphism based on charge differences.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alper, C. A. and Propp, R. P.: Clin. Res. 15: 291 (Abstract), 1967
Avrilommi, H.: Capacity of complement C3 phenotypes to bind onto mononuclear cells in man. Nature 251: 740–741, 1974
Berg, K. and Heiberg, A.: Linkage between hypercholesterolaemia with xanthematosis and the C3 polymorphism confirmed. Cytogenet. Cell Genet. 22: 621–623, 1978
Brönnestam, R.: Studies of the C3 polymorphism. Relationship between C3 phenotypes and rheumatoid arthritis. Hum. Hered. 23: 206–213, 1973
Davies, K. E., Jackson, J., Williamson, R., Harper, P. S., Ball, S., Sarfarazi, M., Meredith, L., and Fey, G.: Linkage analysis of myotonic dystrophy and sequences on chromosome 19 using a cloned complement 3 gene probe. J. Med. Genet. 20: 259–263, 1983
Hammer, C. H., Wirtz, G. H., Renfer, L., Gresham, H. D., and Tack, B. F.: Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256: 3995–4006, 1981
Koch, C., Skjødt, K., and Laursen, I.: A simple immunoblotting method after separation of proteins in agarose gel. J. Immunol. Methods 84: 271–278, 1985
Köhler, G. and Milstein, C.: Continous culture of fused cells secreting antibody of predefined specificity. Nature 256: 495–497, 1975
Kristensen, B. O. and Bruun-Petersen, G. B.: Association between coronary heart disease and the C3F-gene in essential hypertension. Circulation 58: 622–625, 1979
Larsen, S. O.: A general APL program for maximum likelihood estimation or other function maximization using numerical differentiation. Comput. Programs Biomed. 15: 23–25, 1982
Markert, C. L.: The molecular basis for isozymes. Ann. N. Y. Acad. Sci. 151: 14–40, 1968
McLean, R. H., Weinstein, A., Damjanov, I., and Rothfield, N.: Hypomorphic variant of C3, arthritis, and chronic glomerulonephritis. J. Pediatr. 93: 937–943, 1978
Müller-Eberhard, H. J. and Schreiber, R. D.: Molecular biology and chemistry of the alternative pathway of complement. Adv. Immunol. 29: 1–53, 1980
Natsuume-Sakai, S., Moriwaki, K., Amano, S., Hayakawa, J., Kaidoh, T., and Takahashi, M.: Allotypes of C3 in laboratory and wild mouse distinguished by alloantisera. J. Immunol. 123: 216–221, 1979
Podack, E. R. and Tschopp, J.: Membrane attack by complement. Mol. Immunol. 21: 589–603, 1984
Reid, K. B. M. and Porter, R. R.: The proteolytic activation systems of complement. Annu. Rev. Biochem. 50: 433–464, 1981
Rittner, C. and Rittner, B.: Report 1973–1974 of the reference laboratory for the polymorphism of the third component (C3) of the human complement system. Vox Sang. 27: 464–472, 1974
Sørensen, H. and Dissing, J.: C3 polymorphism in a group of old arteriosclerotic patients. Hum. Hered. 22: 466–472, 1972
Whitehead, A. S., Solomon, E., Chambers, S., Bodmer, W. F., Povey, S., and Fey, G.: Assignment of the structural gene for the third component of human complement to chromosome 19. Proc. Natl. Acad. Sci. U.S.A. 79: 5021–5025, 1982
Wieme, R.J. and Demeulenaere, L.: Genetically determined electrophoretic variant of the human complement component C'3. Nature 214: 1042–1043, 1967
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koch, C., Behrendt, N. A novel polymorphism of human complement component C3 detected by means of a monoclonal antibody. Immunogenetics 23, 322–325 (1986). https://doi.org/10.1007/BF00398796
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00398796